Mayne Pharma Group (MAYNF) Short Interest Ratio & Short Volume $3.95 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Mayne Pharma Group Short Interest DataMayne Pharma Group (MAYNF) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1,887 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$437.50Short Interest Ratio0.2 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume0 sharesAverage Trading Volume1,887 sharesToday's Volume Vs. Average0% Short Selling Mayne Pharma Group? Sign up to receive the latest short interest report for Mayne Pharma Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMAYNF Short Interest Over TimeMAYNF Days to Cover Over TimeMAYNF Percentage of Float Shorted Over Time Mayne Pharma Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025100 shares $437.50 No ChangeN/A0.2 $4.38 3/15/2025100 shares $433.50 No ChangeN/A0.2 $4.34 2/28/2025100 shares $460.00 -99.1%N/A0.1 $4.60 2/15/202510,800 shares $39,744.00 No ChangeN/A3 $3.68 11/30/20249,900 shares $33,660.00 No ChangeN/A3.1 $3.40 10/31/2024500 shares $1,500.00 No ChangeN/A0.6 $3.00 7/15/2024200 shares $600.00 +100.0%N/A2 $3.00 6/30/2024100 shares $300.00 No ChangeN/A0 $3.00 6/15/2024100 shares $326.50 No ChangeN/A0.6 $3.27 5/31/2024100 shares $333.50 -75.0%N/A0.5 $3.34 Get the Latest News and Ratings for MAYNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mayne Pharma Group and its competitors with MarketBeat's FREE daily newsletter. 5/15/2024400 shares $1,792.00 -71.4%N/A2 $4.48 4/30/20241,400 shares $6,244.00 -62.2%N/A14 $4.46 4/15/20243,700 shares $16,539.00 No ChangeN/A7.4 $4.47 1/15/20242,000 shares $8,500.00 No ChangeN/A20 $4.25 7/31/2023200 shares $678.00 No ChangeN/A2 $3.39 7/15/2023200 shares $583.00 No ChangeN/A0.1 $2.92 6/30/2023200 shares $514.00 No ChangeN/A2 $2.57 6/15/2023200 shares $514.00 No ChangeN/A0.2 $2.57 5/31/2023200 shares $474.00 -96.0%N/A0.3 $2.37 5/15/20235,000 shares $13,600.00 +4,900.0%N/A7.1 $2.72 4/30/2023100 shares $263.00 No ChangeN/A0 $2.63 4/15/2023100 shares $263.00 No ChangeN/A0.3 $2.63 3/31/2023100 shares $255.00 No ChangeN/A0 $2.55 3/15/2023100 shares $257.50 -50.0%N/A0 $2.58 2/28/2023200 shares $410.00 -87.5%N/A0.1 $2.05 2/15/20231,600 shares $4,096.00 No ChangeN/A16 $2.56 1/15/2023825,200 shares $2.51 million -39.9%N/A412.6 $3.04 12/30/20221,372,200 shares $171,525.00 +2,081.6%N/A3.9 $0.13 12/15/202262,900 shares $10,007.39 +88.9%N/A2.1 $0.16 11/30/202233,300 shares $5,661.00 -0.3%N/A3 $0.17 11/15/202233,400 shares $5,958.56 +0.3%N/A2.6 $0.18 10/31/202233,300 shares $5,950.71 No ChangeN/A2.8 $0.18 10/15/202233,300 shares $6,656.67 No ChangeN/A5.2 $0.20 9/30/202233,300 shares $5,887.44 No ChangeN/A3 $0.18 9/15/202233,300 shares $6,603.39 -14.4%N/A22.2 $0.20 8/31/202238,900 shares $8,558.00 -79.7%N/A5.8 $0.22 8/15/2022191,500 shares $45,825.95 +277.7%N/A18.2 $0.24 7/31/202250,700 shares $12,335.31 -5.6%N/A2.8 $0.24 7/15/202253,700 shares $11,545.50 -40.1%N/A6.6 $0.22 6/30/202289,600 shares $13,959.68 -73.2%N/A3.3 $0.16Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 6/15/2022334,100 shares $56,797.00 -0.1%N/A29.3 $0.17 5/31/2022334,500 shares $69,141.15 -54.4%N/A21.7 $0.21 5/15/2022733,200 shares $139,308.00 -29.0%N/A146.6 $0.19 4/30/20221,033,200 shares $216,972.00 -44.3%N/A258.3 $0.21 4/15/20221,855,200 shares $365,288.88 +26.0%N/A152.1 $0.20 3/31/20221,472,200 shares $279,718.00 +8.9%N/A320 $0.19 3/15/20221,351,500 shares $208,266.15 +75.5%N/A95.9 $0.15 2/28/2022770,000 shares $141,295.00 -36.4%N/A34.2 $0.18 2/15/20221,211,500 shares $240,240.45 +31.5%N/A149.6 $0.20 1/31/2022921,200 shares $153,103.44 -13.6%N/A50.6 $0.17 1/15/20221,065,900 shares $214,778.85 -8.2%N/A31.4 $0.20 12/31/20211,160,900 shares $241,467.20 +10.4%N/A11.2 $0.21 12/15/20211,051,300 shares $212,783.12 +17.0%N/A22.5 $0.20 11/30/2021898,800 shares $181,557.60 -54.1%N/A7 $0.20 11/15/20211,958,500 shares $449,867.45 +111.7%N/A93.3 $0.23 10/29/2021925,100 shares $226,001.93 -1.2%N/A237.2 $0.24 10/15/2021936,200 shares $218,977.18 -10.1%N/A54.7 $0.23 9/30/20211,041,500 shares $218,267.16 -27.9%N/A231.4 $0.21 9/15/20211,445,000 shares $331,338.50 -5.9%N/A23 $0.23 8/31/20211,535,100 shares $336,186.90 +328.6%N/A46.8 $0.22 8/13/2021358,200 shares $72,642.96 -1.5%N/A36.6 $0.20 7/30/2021363,700 shares $88,015.40 +19.6%N/A32.8 $0.24 7/15/2021304,200 shares $73,312.20 +51.8%N/A78 $0.24 6/30/2021200,400 shares $49,699.20 No ChangeN/A31.3 $0.25 5/28/202120,000 shares $5,698.00 +1,011.1%N/A3.2 $0.28 5/14/20211,800 shares $527.40 -10.0%N/A0.1 $0.29 4/30/20212,000 shares $633.10 -67.2%N/A0 $0.32 4/15/20216,100 shares $2,061.80 +19.6%N/A0.1 $0.34 3/31/20215,100 shares $1,379.55 -69.1%N/A0.1 $0.27 3/15/202116,500 shares $4,075.50 +75.5%N/A1.6 $0.25 2/26/20219,400 shares $2,227.80 +17.5%N/A0.8 $0.24 2/12/20218,000 shares $2,060.00 -64.3%N/A0.9 $0.26 1/29/202122,400 shares $5,936.00 +966.7%N/A2.6 $0.27 1/15/202117,900 shares $5,083.60 -94.1%N/A2.8 $0.28 12/31/20209,800 shares $2,459.80 -45.3%N/A1.3 $0.25 12/15/202017,900 shares $4,542.13 -94.1%N/A2.8 $0.25 11/30/2020302,100 shares $83,681.70 -46.5%N/A38.7 $0.28 11/15/2020564,400 shares $136,133.28 +88.1%N/A209 $0.24 10/30/2020300,000 shares $69,600.00 -47.9%N/A230.8 $0.23 10/15/2020576,200 shares $140,592.80 +81.2%N/A169.5 $0.24 9/30/2020318,000 shares $90,630.00 +7.6%N/A144.5 $0.29 9/15/2020295,600 shares $78,334.00 +6.1%N/A739 $0.27 8/31/2020278,600 shares $68,758.48 +0.9%N/A2.9 $0.25 8/14/2020276,200 shares $70,403.38 -2.1%N/A15.6 $0.25 7/31/2020282,100 shares $80,539.55 -44.8%N/A403 $0.29 7/15/2020511,300 shares $145,720.50 -12.0%N/A222.3 $0.29 6/30/2020581,200 shares $145,300.00 -2.3%N/A322.9 $0.25 6/15/2020594,900 shares $180,254.70 +62.9%N/A64 $0.30 5/29/2020365,200 shares $107,186.20 +64.1%N/A405.8 $0.29 5/15/2020222,500 shares $60,520.00 -81.9%N/A26.2 $0.27Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… MAYNF Short Interest - Frequently Asked Questions What is Mayne Pharma Group's current short interest? Short interest is the volume of Mayne Pharma Group shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 100 shares of MAYNF short. Learn More on Mayne Pharma Group's current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Mayne Pharma Group stock? Short selling MAYNF is an investing strategy that aims to generate trading profit from Mayne Pharma Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mayne Pharma Group? A short squeeze for Mayne Pharma Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MAYNF, which in turn drives the price of the stock up even further. How often is Mayne Pharma Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MAYNF, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies AZNCF Short Interest CSPCY Short Interest JCRRF Short Interest KYKOF Short Interest OPHLY Short Interest ORINF Short Interest OTSKY Short Interest OTSKF Short Interest PTKFF Short Interest RHHVF Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MAYNF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mayne Pharma Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mayne Pharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAYNF Stock Free MAYNF Stock Alerts